Genius Sports' Legend Bet Faces Its First Real Scorecard

Genius Sports Limited (GENI) reports first-quarter 2026 earnings on May 7, 2026, before market open, with analysts expecting a loss of $-0.09 per share. The central question is whether the sports data and technology company can demonstrate continued momentum from its recently announced Legend acquisition while navigating a challenging path toward profitability. With the stock trading at $4.40—down sharply from its 200-day moving average of $9.31—investors will scrutinize whether management's aggressive growth strategy can translate into sustainable earnings improvement.

Part 1: Earnings Preview

Genius Sports operates as the official data, technology, and broadcast partner powering the global ecosystem connecting sports, betting, and media. The company generates revenue through three segments: Betting Technology, Content & Services (which drove 70% of Q4 2025 revenue), Media Technology, Content & Services, and Sports Technology & Services. This positioning makes GENI a critical infrastructure provider as sports betting and digital media continue converging globally.

For the first quarter ending March 2026, analysts expect GENI to report a loss of $-0.09 per share on May 7 before market open. The most recently reported quarter (Q4 2025, announced March 4, 2026) delivered an actual EPS of $-0.03, missing the $0.02 consensus by $0.10. Comparing to the same quarter last year, the $-0.09 estimate represents a 200% deterioration from the $-0.03 reported in Q1 2025, though this reflects the company's investment phase following the Legend acquisition announcement.

Three key themes define this earnings story:

Legend Acquisition Integration: Genius Sports entered a definitive agreement to acquire Legend during Q1, creating what management calls "a digital sports and gaming media powerhouse." The transaction is expected to close in Q2 2026 and would boost the combined entity to approximately $1.1 billion in revenue with $320-330 million in Adjusted EBITDA on a 2026 annualized pro forma basis. Investors will scrutinize integration plans, cost synergies, and whether the deal accelerates the path to profitability or extends the investment period.

Media Business Inflection Point: Q4 2025 saw Media Technology, Content & Services revenue surge 96% year-over-year to $58.2 million, driven by new partnerships with major brands and agencies including PMG and Publicis Sports. Management characterized this as "reaching a clear inflection point" with "accelerating momentum and growing demand from the world's largest brands." Whether this momentum sustained through Q1—traditionally a slower quarter for sports advertising—will be critical for validating the growth narrative.

Profitability Timeline Amid Heavy Losses: Despite revenue growth of 31% in 2025, GENI posted a net loss of $111.6 million for the full year, worsening from $63.0 million in 2024. The company's Adjusted EBITDA margin of 20.4% shows operational leverage, but GAAP profitability remains elusive. With the stock down 59% year-over-year, investors need clarity on when the business model transitions from growth-at-all-costs to sustainable profitability.

Analyst commentary ahead of the release reflects cautious optimism tempered by execution concerns. The 15 Strong Buy ratings (out of 19 total analysts) and $10.78 mean price target suggest Wall Street believes in the long-term opportunity, but the consistent earnings misses—GENI has missed estimates in three of the last four quarters—have eroded confidence in near-term guidance. One analyst noted that while the Legend deal "further strengthens Genius' strategic and financial profile," the company must demonstrate it can integrate acquisitions while controlling costs in a capital-intensive business model.

Part 2: Historical Earnings Performance

Genius Sports has established a troubling pattern of earnings disappointments over the past year. In the most recent quarter (Q4 2025), the company reported $-0.03 per share against a $0.02 consensus, representing a 250% miss. This followed Q3 2025's $-0.11 result that also missed expectations, and Q2 2025's $-0.21 loss that significantly underperformed the break-even estimate.

The only bright spot in the four-quarter history came in Q1 2025, when GENI reported $-0.03 versus the $-0.05 estimate, delivering a 40% beat. However, this lone success is overshadowed by the subsequent three consecutive misses, suggesting the company struggles with forecasting accuracy during periods of rapid growth and investment.

The magnitude of misses has been particularly concerning. The Q4 2025 shortfall of $0.10 per share and the Q2 2025 miss (where actual results were substantially worse than the break-even estimate) indicate operational challenges that extend beyond normal quarterly variance. This pattern of underperformance has likely contributed to the stock's 59% decline over the past year, as investors lose confidence in management's ability to deliver on earnings guidance even as revenue growth remains strong.

Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

Genius Sports typically reports earnings before market open, meaning Day 0 represents the first full trading session where investors react to results, while Day +1 captures follow-through momentum.

Historical price behavior reveals significant volatility around GENI earnings releases, with an average absolute Day 0 move of 7.24% and Day +1 follow-through averaging 2.39%. The stock has demonstrated wide intraday ranges, averaging 11.49% on earnings day and 6.32% the following session, reflecting substantial uncertainty and active repositioning by traders.

The directional pattern shows no clear bias—recent quarters have produced both sharp rallies and steep declines. The most dramatic reaction came in November 2024 with a 17.20% Day 0 surge, while March 2026's most recent report triggered a 6.65% decline. Notably, Day +1 moves tend to be smaller and sometimes reverse the initial reaction, as seen in August 2025 when a 4.50% Day 0 drop was followed by a 2.49% Day +1 recovery.

Investors should prepare for substantial price movement, with the historical data suggesting a realistic range of 5-15% on earnings day itself. The wide intraday ranges indicate that initial reactions can be volatile, with prices often swinging significantly before settling into a closing direction.

Part 2.2: Options Market Expected Move

The options market is pricing an 18.35% expected move for the May 15 expiration (9 days out), implying a range between $3.59 and $5.21. This expected move is substantially higher than the 7.24% average historical Day 0 move and even exceeds the 11.49% average Day 0 range, suggesting options traders are anticipating above-average volatility for this particular release—likely reflecting uncertainty around the Legend acquisition impact and the company's widening losses.

Part 3: What Analysts Are Saying

Analyst sentiment remains overwhelmingly bullish despite recent execution challenges, with the consensus rating at 4.63 out of 5.0—firmly in Strong Buy territory. The breakdown shows 15 Strong Buys, 1 Moderate Buy, and 3 Holds, with zero sell ratings. This lopsided distribution reflects Wall Street's conviction in GENI's long-term positioning at the intersection of sports data, betting, and media, even as near-term profitability remains elusive.

The average price target of $10.78 implies 145% upside from the current $4.40 price, with estimates ranging from a $5.00 low to a $15.00 high. This wide target range—spanning 200% from bottom to top—underscores the divergent views on valuation and execution risk. The most bullish analysts see GENI as a transformational infrastructure play in the rapidly growing sports betting ecosystem, while more conservative voices acknowledge the competitive pressures and integration risks associated with the Legend acquisition.

Analyst sentiment has remained unchanged over the past month, with rating counts and the average recommendation holding steady at 4.63. This stability suggests Wall Street is taking a wait-and-see approach, maintaining conviction in the strategic vision while acknowledging that the next several quarters will be critical for validating the growth-to-profitability transition. The lack of downgrades despite three consecutive earnings misses indicates analysts view the shortfalls as growing pains rather than fundamental business model flaws, though patience may be wearing thin if Q1 2026 delivers another significant disappointment.

Part 4: Technical Picture

The technical picture heading into earnings is decidedly bearish, with the Barchart Technical Opinion showing a 100% Sell signal that has remained consistently negative over the past week and month. At $4.40, GENI trades well below all major moving averages, with the stock sitting 53% below its 200-day moving average of $9.31 and 9% below even the short-term 50-day moving average of $4.82.

Timeframe Analysis:

• Short-term (100% Sell): Strong sell signal indicates immediate downward pressure with no near-term momentum support
• Medium-term (100% Sell): Persistent sell reading confirms the intermediate-term trend remains firmly negative
• Long-term (100% Sell): Bearish signal across the longer timeframe reflects sustained weakness and deteriorating investor confidence

Trend Characteristics: The signal strength is classified as Strong with a Weakening direction, indicating the downtrend is not only firmly established but continues to deteriorate heading into the earnings release.

The stock has found minimal support near current levels, trading just above its 10-day moving average of $4.38 but below the 20-day average of $4.43. The cascading series of moving averages—each successively higher—creates significant overhead resistance that would need to be overcome for any sustained post-earnings rally. The 50-day moving average at $4.82 represents the first major hurdle, followed by the 100-day at $6.97.

From a technical perspective, GENI enters earnings in a vulnerable position with no meaningful support levels nearby and substantial overhead resistance. The uniformly bearish signals across all timeframes suggest the market has little confidence in a positive surprise, and any disappointment could accelerate the existing downtrend. For a meaningful reversal, the stock would need to not only beat estimates but also reclaim the $4.82 level (50-day MA) and hold it as support—a tall order given the three consecutive earnings misses and weakening technical momentum. The setup is decidedly cautionary, with risk skewed to the downside unless management delivers a significant positive surprise on both results and forward guidance.